Related Experiment Videos
Flow cytometric DNA analysis of pleural effusions
M S Huang1, M S Tsai, T H Wang
1Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.
Gaoxiong Yi Xue Ke Xue Za Zhi = the Kaohsiung Journal of Medical Sciences
|December 1, 1992
Summary
Flow cytometry (FCM) enhances pleural effusion analysis by detecting abnormal DNA content (aneuploidy). This method, combined with conventional cytology, improves diagnostic accuracy for lung cancer detection in effusions.
Area of Science:
- Oncology
- Cytopathology
- Flow Cytometry
Background:
- Pleural effusion diagnosis can be challenging.
- Conventional cytology has limitations in detecting malignancy.
Purpose of the Study:
- To evaluate flow cytometry (FCM) as an adjunct to conventional cytology for pleural effusion analysis.
- To detect aneuploidy in pleural fluid cells to aid in cancer diagnosis.
Main Methods:
- Analysis of 71 pleural effusion cases using conventional cytology and FCM.
- FCM utilized propidium iodide staining to assess DNA content and identify aneuploidy.
- Comparison of FCM results with cytologic findings and patient diagnoses.
Main Results:
- All 38 benign effusions were diploid by FCM.
- In 33 lung cancer cases, 52% showed aneuploidy by FCM.
- FCM identified aneuploidy in 2 cytologically negative samples, improving diagnostic yield.
Conclusions:
- FCM is a rapid and valuable tool for pleural effusion analysis.
- Combining FCM with conventional cytopathology offers high diagnostic accuracy (100% specificity, 94% sensitivity).
- FCM can serve as a crucial adjunct to cytopathology for improved lung cancer detection.